Elephas Biosciences and Tes Pharma, an Italy-based biopharmaceutical company focused on developing therapeutics for unmet medical needs, announced today that they are collaborating to advance translational research for lung therapy….
Elephas Biosciences announced recently that Neuberg Diagnostics will become its commercial partner in India. According to a release, Neuberg will process tumor biopsy samples on the elive platform at its…
Elephas Biosciences Corporation and Invitrocue Pte. Ltd, have partnered to expand personalized oncology in Southeast Asia, the company announced recently. Invitrocue will serve as Elephas’ commercial partner for the elive…
Elephas is collaborating with Mithrl, an AI company focused on accelerating research through its Scientific Decision Engine (SDE), the company announced recently. “Partnering with Mithrl enables us to more fully…
Elephas Biosciences Corporation is partnering with the University of Louisville on a new research opportunity that will evaluate the impact of a combination therapy of surgical intervention and immunotherapy in…
Elephas Biosciences Corporation raised $40 million in a Series B-2 fundraising round, the company announced today. According to a release, the round included participation from existing investors including Northpond Ventures,…
Elephas Biosciences announced today that its first cancer patient was screened at inDNA Life Sciences in India, as part of a study that aims to demonstrate that the Elphas Live…
Elephas will collaborate with the Mayo Clinic Comprehensive Cancer Center to develop of oncology imaging diagnostics platform that will predict response to immunotherapy, the company announced today. “We are excited…
Elephas has closed a $55 million Series C funding round led by Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB), the company announced today. “We remain intensely…
Elephas Biosciences Corporation, a biotech company that developed an oncology diagnostics platform to predict response to immunotherapy, has raised $41.5 million in a Series B funding round, the company announced…
